Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO33150 | Artocarpus communis | Species | Moraceae | Eukaryota | Roots | Khon Kaen, Thailand | 2009-DEC |
PMID[25537111] |
NPO31552 | Lonicera morrowii | Species | Caprifoliaceae | Eukaryota | HerDing* | |||
NPO9090 | Patrinia villosa | Species | Caprifoliaceae | Eukaryota | HerDing* | |||
NPO9402 | Morus mongolica | Species | Moraceae | Eukaryota | TCM_Taiwan* | |||
NPO9402 | Morus mongolica | Species | Moraceae | Eukaryota | HerDing* | |||
NPO29694 | Mori cortex | NA | NA | NA | TCMSP* | |||
NPO9002 | Herba patriniae | NA | NA | NA | TCMSP* | |||
NPO15835 | Glycyrrhiza | Species | Fabaceae | Eukaryota | TCMSP* | |||
NPO20455 | Hydnocarpi anthelminticae semen | NA | NA | NA | TCMSP* | |||
NPO12588 | Cornus officinalis | Species | Cornaceae | Eukaryota | TCMSP* | |||
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | TM-MC* | |||
NPO9402 | Morus mongolica | Species | Moraceae | Eukaryota | TCMID* | |||
NPO12588 | Cornus officinalis | Species | Cornaceae | Eukaryota | TCMID* | |||
NPO14802.1 | Lonicera tatarica var. morrowii | Varieties | Caprifoliaceae | Eukaryota | TCMID* | |||
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | TCMID* | |||
NPO17949 | Gentiana thunbergii | Species | Gentianaceae | Eukaryota | TCMID* | |||
NPO9090 | Patrinia villosa | Species | Caprifoliaceae | Eukaryota | TCMID* | |||
NPO26579 | Artocarpus fretessi | Species | Moraceae | Eukaryota | TCMID* | |||
NPO11688 | Adoxa moschatellina | Species | Adoxaceae | Eukaryota | TCMID* | |||
NPO11796 | Morus australis | Species | Moraceae | Eukaryota |
PMID[9358644] |
|||
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota |
PMID[9358644] |
|||
NPO8352 | Canthium berberidifolium | Species | Rubiaceae | Eukaryota | UNPD* | |||
NPO10498 | Artocarpus dadah | Species | Moraceae | Eukaryota | UNPD* | |||
NPO11740 | Sagenomella striatispora | Species | Trichocomaceae | Eukaryota | UNPD* | |||
NPO11688 | Adoxa moschatellina | Species | Adoxaceae | Eukaryota | HerDing* | |||
NPO12588 | Cornus officinalis | Species | Cornaceae | Eukaryota | HerDing* | |||
NPO17949 | Gentiana thunbergii | Species | Gentianaceae | Eukaryota | HerDing* | |||
NPO26579 | Artocarpus fretessi | Species | Moraceae | Eukaryota | HerDing* | |||
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | TCM_Taiwan* | |||
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | HerDing* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 100000 | nM | 16038536 |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 100000 | nM | 16038536 |
NPT2 | Others | Unspecified | Activity | = | 81.8 | % | 9358644 | |
NPT2 | Others | Unspecified | Activity | = | 0 | % | 9358644 | |
NPT2 | Others | Unspecified | Activity | = | 74.2 | % | 9358644 | |
NPT2 | Others | Unspecified | Activity | = | 82.8 | % | 9358644 | |
NPT2 | Others | Unspecified | Activity | = | 5.3 | % | 9358644 | |
NPT2 | Others | Unspecified | Activity | = | 62.5 | % | 9358644 | |
NPT2 | Others | Unspecified | Activity | = | 81.3 | % | 9358644 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Inhibition | = | 1 | % | 20485427 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 8 | % | 20485427 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 89 | % | 20485427 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 5 | % | 20485427 |
NPT174 | Organism | Streptococcus | Streptococcus | EC50 | = | 2965 | nM | PubChem BioAssay data set |
NPT1252 | Organism | Streptococcus sp. 'group A' | Streptococcus sp. 'group A' | EC50 | = | 2715 | nM | PubChem BioAssay data set |
NPT1254 | Individual Protein | Streptokinase A | Streptococcus pyogenes serotype M1 | EC50 | = | 1234 | nM | PubChem BioAssay data set |
NPT1254 | Individual Protein | Streptokinase A | Streptococcus pyogenes serotype M1 | EC50 | = | 1149 | nM | PubChem BioAssay data set |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 18356.4 | nM | PubChem BioAssay data set | |
NPT740 | Individual Protein | Beta-secretase 1 | Homo sapiens | Ki | = | 64100 | nM | 21511472 |
NPT740 | Individual Protein | Beta-secretase 1 | Homo sapiens | IC50 | = | 59400 | nM | 21511472 |
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 100000 | nM | 21319773 |
NPT324 | Individual Protein | Cyclooxygenase-1 | Ovis aries | IC50 | = | 100000 | nM | 21319773 |
NPT570 | Individual Protein | Arachidonate 5-lipoxygenase | Homo sapiens | IC50 | = | 100000 | nM | 21319773 |
NPT1119 | Individual Protein | Arachidonate 12-lipoxygenase | Homo sapiens | IC50 | = | 100000 | nM | 21319773 |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 15848.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14125.4 | nM | PubChem BioAssay data set | ||
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 26679.5 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 6309.6 | nM | PubChem BioAssay data set | |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 8912.5 | nM | PubChem BioAssay data set | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT439 | Individual Protein | Butyrylcholinesterase | Homo sapiens | IC50 | = | 1700 | nM | 10.1007/s00044-012-0353-y |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | Ki | = | 3100 | nM | 10.1007/s00044-012-0353-y |
NPT2 | Others | Unspecified | Potency | 20596.2 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 29092.9 | nM | PubChem BioAssay data set | |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT920 | Individual Protein | Alpha-synuclein | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT446 | Individual Protein | Rap guanine nucleotide exchange factor 3 | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT196 | Cell Line | AGS | Homo sapiens | Activity | = | 25 | % | 25537111 |
NPT942 | Individual Protein | Glucose transporter | Homo sapiens | Inhibition | = | 5.72 | % | 10.6019/CHEMBL3433997 |
NPT943 | Individual Protein | Hexose transporter 1 | Plasmodium falciparum | Inhibition | = | 4.6 | % | 10.6019/CHEMBL3433997 |
NPT944 | Individual Protein | Glucose transporter | Leishmania mexicana | Inhibition | = | 6.57 | % | 10.6019/CHEMBL3433997 |
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | = | 24000 | nM | 26829656 | |
NPT1125 | Cell Line | T98G | Homo sapiens | IC50 | = | 24000 | nM | 26829656 |
NPT2 | Others | Unspecified | Activity | = | 29 | % | 26829656 | |
NPT2 | Others | Unspecified | Activity | = | 10 | % | 26829656 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC62840 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC299080 |
1.0 | High Similarity | NPC59739 |
1.0 | High Similarity | NPC293852 |
1.0 | High Similarity | NPC214236 |
1.0 | High Similarity | NPC217083 |
1.0 | High Similarity | NPC78803 |
0.9783 | High Similarity | NPC38219 |
0.9783 | High Similarity | NPC219915 |
0.9781 | High Similarity | NPC156590 |
0.9781 | High Similarity | NPC205006 |
0.9781 | High Similarity | NPC118840 |
0.9781 | High Similarity | NPC64908 |
0.9781 | High Similarity | NPC147688 |
0.9779 | High Similarity | NPC220062 |
0.9779 | High Similarity | NPC96565 |
0.9779 | High Similarity | NPC301217 |
0.9779 | High Similarity | NPC303633 |
0.9779 | High Similarity | NPC216978 |
0.9779 | High Similarity | NPC55018 |
0.9714 | High Similarity | NPC166757 |
0.9714 | High Similarity | NPC97716 |
0.9714 | High Similarity | NPC237635 |
0.9714 | High Similarity | NPC104406 |
0.9714 | High Similarity | NPC201731 |
0.9714 | High Similarity | NPC14001 |
0.9714 | High Similarity | NPC24673 |
0.9714 | High Similarity | NPC79469 |
0.9712 | High Similarity | NPC319752 |
0.971 | High Similarity | NPC11561 |
0.971 | High Similarity | NPC226636 |
0.9708 | High Similarity | NPC172986 |
0.9708 | High Similarity | NPC159275 |
0.9708 | High Similarity | NPC241100 |
0.9708 | High Similarity | NPC270883 |
0.9708 | High Similarity | NPC305355 |
0.9708 | High Similarity | NPC261227 |
0.9708 | High Similarity | NPC475680 |
0.9708 | High Similarity | NPC150522 |
0.9708 | High Similarity | NPC235239 |
0.9706 | High Similarity | NPC201395 |
0.9645 | High Similarity | NPC244407 |
0.9645 | High Similarity | NPC266572 |
0.9645 | High Similarity | NPC189087 |
0.9645 | High Similarity | NPC321623 |
0.9645 | High Similarity | NPC161191 |
0.9645 | High Similarity | NPC6511 |
0.9643 | High Similarity | NPC20488 |
0.9643 | High Similarity | NPC176229 |
0.9643 | High Similarity | NPC111786 |
0.9643 | High Similarity | NPC474161 |
0.9643 | High Similarity | NPC312973 |
0.9643 | High Similarity | NPC220418 |
0.9643 | High Similarity | NPC470647 |
0.9643 | High Similarity | NPC301276 |
0.9643 | High Similarity | NPC246948 |
0.9643 | High Similarity | NPC54577 |
0.9643 | High Similarity | NPC475052 |
0.9643 | High Similarity | NPC88964 |
0.9643 | High Similarity | NPC476088 |
0.9643 | High Similarity | NPC57470 |
0.9643 | High Similarity | NPC267375 |
0.9643 | High Similarity | NPC195621 |
0.9643 | High Similarity | NPC142405 |
0.9643 | High Similarity | NPC67805 |
0.9643 | High Similarity | NPC83357 |
0.9643 | High Similarity | NPC214774 |
0.9638 | High Similarity | NPC110969 |
0.9638 | High Similarity | NPC14871 |
0.9638 | High Similarity | NPC103362 |
0.9638 | High Similarity | NPC282300 |
0.9635 | High Similarity | NPC18260 |
0.9635 | High Similarity | NPC78913 |
0.9635 | High Similarity | NPC217186 |
0.9635 | High Similarity | NPC53181 |
0.9577 | High Similarity | NPC5173 |
0.9574 | High Similarity | NPC296998 |
0.9574 | High Similarity | NPC180477 |
0.9574 | High Similarity | NPC473077 |
0.9574 | High Similarity | NPC297886 |
0.9574 | High Similarity | NPC23728 |
0.9574 | High Similarity | NPC283234 |
0.9574 | High Similarity | NPC110303 |
0.9574 | High Similarity | NPC249942 |
0.9571 | High Similarity | NPC257236 |
0.9571 | High Similarity | NPC278175 |
0.9571 | High Similarity | NPC234629 |
0.9571 | High Similarity | NPC311741 |
0.9568 | High Similarity | NPC200694 |
0.9568 | High Similarity | NPC144499 |
0.9565 | High Similarity | NPC69769 |
0.9562 | High Similarity | NPC470668 |
0.9562 | High Similarity | NPC470669 |
0.9562 | High Similarity | NPC17848 |
0.9559 | High Similarity | NPC13408 |
0.951 | High Similarity | NPC471984 |
0.951 | High Similarity | NPC188403 |
0.9507 | High Similarity | NPC132592 |
0.9507 | High Similarity | NPC296869 |
0.9507 | High Similarity | NPC161864 |
0.9507 | High Similarity | NPC469933 |
0.9507 | High Similarity | NPC208303 |
0.9507 | High Similarity | NPC160821 |
0.9504 | High Similarity | NPC124729 |
0.9504 | High Similarity | NPC329678 |
0.95 | High Similarity | NPC190637 |
0.95 | High Similarity | NPC478086 |
0.95 | High Similarity | NPC212932 |
0.95 | High Similarity | NPC18585 |
0.95 | High Similarity | NPC166138 |
0.95 | High Similarity | NPC106985 |
0.95 | High Similarity | NPC9117 |
0.95 | High Similarity | NPC293053 |
0.95 | High Similarity | NPC11700 |
0.95 | High Similarity | NPC24821 |
0.95 | High Similarity | NPC316816 |
0.95 | High Similarity | NPC214166 |
0.9493 | High Similarity | NPC23257 |
0.9489 | High Similarity | NPC157855 |
0.9441 | High Similarity | NPC469932 |
0.9437 | High Similarity | NPC140120 |
0.9433 | High Similarity | NPC131568 |
0.9433 | High Similarity | NPC326500 |
0.9433 | High Similarity | NPC209040 |
0.9433 | High Similarity | NPC216538 |
0.9433 | High Similarity | NPC469953 |
0.9433 | High Similarity | NPC131579 |
0.9433 | High Similarity | NPC273538 |
0.9429 | High Similarity | NPC148757 |
0.9429 | High Similarity | NPC76372 |
0.9429 | High Similarity | NPC32739 |
0.9429 | High Similarity | NPC66515 |
0.9429 | High Similarity | NPC473042 |
0.9429 | High Similarity | NPC166482 |
0.9429 | High Similarity | NPC107572 |
0.9429 | High Similarity | NPC324134 |
0.9429 | High Similarity | NPC161506 |
0.9429 | High Similarity | NPC36181 |
0.9429 | High Similarity | NPC324436 |
0.9429 | High Similarity | NPC194432 |
0.9429 | High Similarity | NPC167624 |
0.9429 | High Similarity | NPC37496 |
0.9429 | High Similarity | NPC166934 |
0.9429 | High Similarity | NPC220998 |
0.9429 | High Similarity | NPC76338 |
0.9429 | High Similarity | NPC227579 |
0.9429 | High Similarity | NPC228504 |
0.9429 | High Similarity | NPC78 |
0.9429 | High Similarity | NPC10937 |
0.9429 | High Similarity | NPC223500 |
0.9429 | High Similarity | NPC328164 |
0.9429 | High Similarity | NPC177354 |
0.9429 | High Similarity | NPC64915 |
0.9429 | High Similarity | NPC265040 |
0.9429 | High Similarity | NPC40833 |
0.9429 | High Similarity | NPC125855 |
0.9429 | High Similarity | NPC182852 |
0.9429 | High Similarity | NPC296917 |
0.9429 | High Similarity | NPC1089 |
0.9429 | High Similarity | NPC306829 |
0.9424 | High Similarity | NPC471587 |
0.942 | High Similarity | NPC248995 |
0.942 | High Similarity | NPC272844 |
0.942 | High Similarity | NPC131130 |
0.942 | High Similarity | NPC254168 |
0.9416 | High Similarity | NPC29353 |
0.9416 | High Similarity | NPC124784 |
0.9416 | High Similarity | NPC127447 |
0.9416 | High Similarity | NPC161196 |
0.9416 | High Similarity | NPC231772 |
0.9416 | High Similarity | NPC473887 |
0.9416 | High Similarity | NPC194281 |
0.9416 | High Similarity | NPC234133 |
0.9416 | High Similarity | NPC174999 |
0.9416 | High Similarity | NPC47815 |
0.9379 | High Similarity | NPC45934 |
0.9375 | High Similarity | NPC471115 |
0.9375 | High Similarity | NPC472633 |
0.9375 | High Similarity | NPC29777 |
0.9375 | High Similarity | NPC151973 |
0.9366 | High Similarity | NPC5820 |
0.9366 | High Similarity | NPC285630 |
0.9366 | High Similarity | NPC154217 |
0.9366 | High Similarity | NPC127059 |
0.9366 | High Similarity | NPC470131 |
0.9366 | High Similarity | NPC470134 |
0.9366 | High Similarity | NPC178343 |
0.9366 | High Similarity | NPC477955 |
0.9366 | High Similarity | NPC473078 |
0.9366 | High Similarity | NPC470133 |
0.9366 | High Similarity | NPC109183 |
0.9366 | High Similarity | NPC470132 |
0.9366 | High Similarity | NPC306488 |
0.9362 | High Similarity | NPC81697 |
0.9362 | High Similarity | NPC188632 |
0.9362 | High Similarity | NPC185276 |
0.9362 | High Similarity | NPC91560 |
0.9362 | High Similarity | NPC149026 |
0.9362 | High Similarity | NPC75049 |
0.9362 | High Similarity | NPC107177 |
0.9362 | High Similarity | NPC143896 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC62840 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9571 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.9433 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.9071 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.9071 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.9007 | High Similarity | NPD1549 | Phase 2 |
0.8929 | High Similarity | NPD1510 | Phase 2 |
0.8919 | High Similarity | NPD7411 | Suspended |
0.8913 | High Similarity | NPD1240 | Approved |
0.8867 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8865 | High Similarity | NPD2796 | Approved |
0.8851 | High Similarity | NPD4380 | Phase 2 |
0.88 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8786 | High Similarity | NPD1607 | Approved |
0.8699 | High Similarity | NPD1511 | Approved |
0.8627 | High Similarity | NPD7075 | Discontinued |
0.8621 | High Similarity | NPD3750 | Approved |
0.8609 | High Similarity | NPD6801 | Discontinued |
0.8581 | High Similarity | NPD1512 | Approved |
0.8553 | High Similarity | NPD7819 | Suspended |
0.8553 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8553 | High Similarity | NPD2801 | Approved |
0.8506 | High Similarity | NPD4381 | Clinical (unspecified phase) |
0.8487 | Intermediate Similarity | NPD1934 | Approved |
0.8446 | Intermediate Similarity | NPD6799 | Approved |
0.8442 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8425 | Intermediate Similarity | NPD2800 | Approved |
0.8425 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8418 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8387 | Intermediate Similarity | NPD3749 | Approved |
0.8375 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8344 | Intermediate Similarity | NPD6959 | Discontinued |
0.8299 | Intermediate Similarity | NPD1243 | Approved |
0.8278 | Intermediate Similarity | NPD5403 | Approved |
0.8276 | Intermediate Similarity | NPD3748 | Approved |
0.8264 | Intermediate Similarity | NPD6651 | Approved |
0.8239 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8235 | Intermediate Similarity | NPD6599 | Discontinued |
0.8231 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8205 | Intermediate Similarity | NPD3882 | Suspended |
0.8187 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8187 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8187 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8151 | Intermediate Similarity | NPD2799 | Discontinued |
0.8146 | Intermediate Similarity | NPD5401 | Approved |
0.8141 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8112 | Intermediate Similarity | NPD2313 | Discontinued |
0.8095 | Intermediate Similarity | NPD2935 | Discontinued |
0.8095 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8061 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.805 | Intermediate Similarity | NPD5494 | Approved |
0.8041 | Intermediate Similarity | NPD2344 | Approved |
0.8039 | Intermediate Similarity | NPD920 | Approved |
0.8037 | Intermediate Similarity | NPD7054 | Approved |
0.8014 | Intermediate Similarity | NPD1203 | Approved |
0.8013 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7988 | Intermediate Similarity | NPD7472 | Approved |
0.7988 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7986 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7986 | Intermediate Similarity | NPD3268 | Approved |
0.7975 | Intermediate Similarity | NPD3818 | Discontinued |
0.7973 | Intermediate Similarity | NPD6099 | Approved |
0.7973 | Intermediate Similarity | NPD6100 | Approved |
0.795 | Intermediate Similarity | NPD6232 | Discontinued |
0.7945 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7945 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7943 | Intermediate Similarity | NPD3225 | Approved |
0.7939 | Intermediate Similarity | NPD5953 | Discontinued |
0.7939 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7927 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7914 | Intermediate Similarity | NPD7473 | Discontinued |
0.7911 | Intermediate Similarity | NPD5402 | Approved |
0.7908 | Intermediate Similarity | NPD2532 | Approved |
0.7908 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7908 | Intermediate Similarity | NPD2534 | Approved |
0.7908 | Intermediate Similarity | NPD2533 | Approved |
0.7905 | Intermediate Similarity | NPD7033 | Discontinued |
0.7905 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7892 | Intermediate Similarity | NPD7251 | Discontinued |
0.7887 | Intermediate Similarity | NPD2797 | Approved |
0.7881 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7862 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7857 | Intermediate Similarity | NPD422 | Phase 1 |
0.7847 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7844 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7843 | Intermediate Similarity | NPD7390 | Discontinued |
0.7832 | Intermediate Similarity | NPD2798 | Approved |
0.7829 | Intermediate Similarity | NPD2309 | Approved |
0.7826 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7821 | Intermediate Similarity | NPD3226 | Approved |
0.7801 | Intermediate Similarity | NPD9717 | Approved |
0.7785 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7784 | Intermediate Similarity | NPD6559 | Discontinued |
0.7763 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7755 | Intermediate Similarity | NPD943 | Approved |
0.7738 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7724 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7711 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7701 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7701 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7682 | Intermediate Similarity | NPD2346 | Discontinued |
0.7671 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7654 | Intermediate Similarity | NPD919 | Approved |
0.7647 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7639 | Intermediate Similarity | NPD3267 | Approved |
0.7639 | Intermediate Similarity | NPD3266 | Approved |
0.7614 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7582 | Intermediate Similarity | NPD2654 | Approved |
0.7578 | Intermediate Similarity | NPD4288 | Approved |
0.7561 | Intermediate Similarity | NPD1247 | Approved |
0.7557 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7557 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7547 | Intermediate Similarity | NPD6585 | Discontinued |
0.7517 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7516 | Intermediate Similarity | NPD1465 | Phase 2 |
0.75 | Intermediate Similarity | NPD1296 | Phase 2 |
0.75 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.747 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7456 | Intermediate Similarity | NPD1729 | Discontinued |
0.7431 | Intermediate Similarity | NPD1608 | Approved |
0.7431 | Intermediate Similarity | NPD3972 | Approved |
0.7412 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7391 | Intermediate Similarity | NPD5890 | Approved |
0.7391 | Intermediate Similarity | NPD5889 | Approved |
0.7386 | Intermediate Similarity | NPD5406 | Approved |
0.7386 | Intermediate Similarity | NPD5405 | Approved |
0.7386 | Intermediate Similarity | NPD5404 | Approved |
0.7386 | Intermediate Similarity | NPD5408 | Approved |
0.7383 | Intermediate Similarity | NPD3764 | Approved |
0.7379 | Intermediate Similarity | NPD4749 | Approved |
0.7375 | Intermediate Similarity | NPD7458 | Discontinued |
0.7371 | Intermediate Similarity | NPD4287 | Approved |
0.7365 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7361 | Intermediate Similarity | NPD1201 | Approved |
0.7358 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7351 | Intermediate Similarity | NPD1933 | Approved |
0.7342 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7337 | Intermediate Similarity | NPD7584 | Approved |
0.7337 | Intermediate Similarity | NPD5940 | Clinical (unspecified phase) |
0.7324 | Intermediate Similarity | NPD9545 | Approved |
0.7321 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD7003 | Approved |
0.7305 | Intermediate Similarity | NPD5710 | Approved |
0.7305 | Intermediate Similarity | NPD9493 | Approved |
0.7305 | Intermediate Similarity | NPD5711 | Approved |
0.7297 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7296 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7288 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7279 | Intermediate Similarity | NPD1470 | Approved |
0.7279 | Intermediate Similarity | NPD1164 | Approved |
0.7267 | Intermediate Similarity | NPD411 | Approved |
0.7267 | Intermediate Similarity | NPD6798 | Discontinued |
0.7267 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7261 | Intermediate Similarity | NPD2354 | Approved |
0.7256 | Intermediate Similarity | NPD2296 | Approved |
0.7237 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7237 | Intermediate Similarity | NPD447 | Suspended |
0.7226 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7222 | Intermediate Similarity | NPD17 | Approved |
0.7214 | Intermediate Similarity | NPD1241 | Discontinued |
0.7202 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7198 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7192 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7171 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7171 | Intermediate Similarity | NPD1613 | Approved |
0.717 | Intermediate Similarity | NPD7212 | Phase 2 |
0.717 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.717 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7168 | Intermediate Similarity | NPD6104 | Discontinued |
0.7153 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD3751 | Discontinued |
0.7134 | Intermediate Similarity | NPD7577 | Discontinued |
0.7134 | Intermediate Similarity | NPD6844 | Discontinued |
0.7133 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7125 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7124 | Intermediate Similarity | NPD230 | Phase 1 |
0.7123 | Intermediate Similarity | NPD1535 | Discovery |
0.7118 | Intermediate Similarity | NPD2403 | Approved |
0.7115 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7115 | Intermediate Similarity | NPD2353 | Approved |
0.7115 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD1019 | Discontinued |
0.7101 | Intermediate Similarity | NPD3787 | Discontinued |
0.7097 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7086 | Intermediate Similarity | NPD8312 | Approved |
0.7086 | Intermediate Similarity | NPD8313 | Approved |
0.707 | Intermediate Similarity | NPD2424 | Discontinued |
0.7051 | Intermediate Similarity | NPD4476 | Approved |
0.7051 | Intermediate Similarity | NPD4477 | Approved |
0.7044 | Intermediate Similarity | NPD3887 | Approved |
0.7044 | Intermediate Similarity | NPD3295 | Clinical (unspecified phase) |
0.7041 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7035 | Intermediate Similarity | NPD7177 | Discontinued |
0.7035 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7021 | Intermediate Similarity | NPD5535 | Approved |
0.7019 | Intermediate Similarity | NPD4662 | Approved |
0.7019 | Intermediate Similarity | NPD4661 | Approved |
PubChem CID   | 5281671 |
ChEMBL   | CHEMBL464006 |
ZINC   |
Molecular Weight:   | 420.16 |
ALogP:   | 0.8118 |
MLogP:   | 3.55 |
XLogP:   | 3.627 |
# Rotatable Bonds:   | 10 |
Polar Surface Area:   | 96.22 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 3 |
# Rings:   | 4 |
# Heavy Atoms:   | 31 |